MedPath

Acyclovir

Acyclovir Tablets, USP Rx only

Approved
Approval ID

8fb01f23-e2bd-6850-e053-2995a90a7cc5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 9, 2022

Manufacturers
FDA

PharmPak, Inc.

DUNS: 175493840

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Acyclovir

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54348-627
Application NumberANDA203834
Product Classification
M
Marketing Category
C73584
G
Generic Name
Acyclovir
Product Specifications
Route of AdministrationORAL
Effective DateOctober 9, 2022
FDA Product Classification

INGREDIENTS (7)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
ACYCLOVIRActive
Quantity: 400 mg in 1 1
Code: X4HES1O11F
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.